I
Irina Lambertz
Researcher at Ghent University
Publications - 11
Citations - 940
Irina Lambertz is an academic researcher from Ghent University. The author has contributed to research in topics: Neuroblastoma & Cancer. The author has an hindex of 8, co-authored 11 publications receiving 855 citations.
Papers
More filters
Journal ArticleDOI
The need for transparency and good practices in the qPCR literature
Stephen A. Bustin,Vladimir Benes,Jeremy A. Garson,Jan Hellemans,Jim F. Huggett,Mikael Kubista,Reinhold Mueller,Tania Nolan,Michael W. Pfaffl,Gregory L. Shipley,Carl T. Wittwer,Peter Schjerling,Philip J. R. Day,Mónica Abreu,Begoña Aguado,Jean-François Beaulieu,Anneleen Beckers,Sara Bogaert,John A. Browne,Fernando Carrasco-Ramiro,Liesbeth Ceelen,Kate L. Ciborowski,Pieter Cornillie,Stephanie Coulon,Ann Cuypers,Sara De Brouwer,Leentje De Ceuninck,Jurgen De Craene,Hélène De Naeyer,Ward De Spiegelaere,Kato Deckers,Annelies Dheedene,Kaat Durinck,Margarida Ferreira-Teixeira,Annelies Fieuw,Jack M. Gallup,Sandra Gonzalo-Flores,Karen Goossens,Femke Heindryckx,Elizabeth Herring,Hans Hoenicka,Laura Icardi,Rolf Jaggi,Farzad Javad,Michael Karampelias,Frederick S. B. Kibenge,Molly J. T. Kibenge,Candy Kumps,Irina Lambertz,Tim Lammens,Amelia Markey,Peter Messiaen,Evelien Mets,Sofia Morais,Alberto Mudarra-Rubio,Justine K. Nakiwala,Hilde Nelis,Pål A. Olsvik,Claudina Perez-Novo,Michelle Plusquin,Tony Remans,Ali Rihani,Paulo Rodrigues-Santos,Pieter Rondou,Rebecca Sanders,Katharina Schmidt-Bleek,Kerstin Skovgaard,Karen Smeets,Laura Tabera,Stefan Toegel,Tim Van Acker,Wim Van den Broeck,Joni Van der Meulen,Mireille Van Gele,Gert Van Peer,Mario Van Poucke,Nadine Van Roy,Sarah Vergult,Joris Wauman,Marina Tshuikina-Wiklander,Erik Willems,Sara Zaccara,Fjoralba Zeka,Jo Vandesompele +83 more
TL;DR: Two surveys of over 1,700 publications whose authors use quantitative real-time PCR (qPCR) reveal a lack of transparent and comprehensive reporting of essential technical information.
Journal ArticleDOI
Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.
Irina Lambertz,David Nittner,Pieter Mestdagh,Geertrui Denecker,Jo Vandesompele,Mike A. Dyer,Jean-Christophe Marine +6 more
TL;DR: It is shown that although monoallelic loss of Dicer1 does not affect normal retinal development, it dramatically accelerates tumor formation on a retinoblastoma-sensitized background and concludes that Dicer 1 functions as a haploinsufficient tumor suppressor.
Journal ArticleDOI
An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity
Jessika Wynendaele,Anja Böhnke,Eleonora Leucci,Søren Jensby Nielsen,Irina Lambertz,Stefanie Hammer,Nadja Sbrzesny,Dana Kubitza,Anja Wolf,Elise Gradhand,Katharina Balschun,Ioana Braicu,Jalid Sehouli,Silvia Darb-Esfahani,Carsten Denkert,Christoph Thomssen,Steffen Hauptmann,Anders H. Lund,Jean-Christophe Marine,Frank Bartel +19 more
TL;DR: It is concluded that acquisition of an illegitimate miR-191 target site causes downregulation of MDM4 expression, thereby significantly delaying ovarian carcinoma progression and tumor-related death and appear to be, at least partly, independent of p53.
Journal ArticleDOI
Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.
Tom Van Maerken,Frank Speleman,Joëlle Vermeulen,Irina Lambertz,Sarah De Clercq,Els De Smet,Nurten Yigit,Vicky Coppens,Jan Philippé,Anne De Paepe,Jean-Christophe Marine,Jo Vandesompele +11 more
TL;DR: Targeted disruption of the p53-MDM2 interaction by the small-molecule MDM2 antagonist nutlin-3 stabilizes p53 and selectively activates the p 53 pathway in neuroblastoma cells with wild-type p53, resulting in a pronounced antiproliferative and cytotoxic effect through induction of G(1) cell cycle arrest and apoptosis.
Journal ArticleDOI
Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Tom Van Maerken,Liesbeth Ferdinande,Jasmien Taildeman,Irina Lambertz,Nurten Yigit,Liesbeth Vercruysse,Ali Rihani,Martin Michaelis,Jindrich Cinatl,Claude Cuvelier,Jean-Christophe Marine,Anne De Paepe,Marc Bracke,Frank Speleman,Jo Vandesompele +14 more
TL;DR: Nutlin-3 activates the p53 pathway and suppresses tumor growth and reduction in the extent of metastatic disease in this model system of chemoresistant neuroblastoma, provided that wild-type p53 is present.